John W. Smither - Chief Financial Officer at Arcutis Biotherapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Financial Officer
Stock Symbol
ARQT on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by John W. Smither since 8/26/2023

Holdings reported by John W. Smither for Arcutis Biotherapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 141K $501K $3.54 Feb 13, 2024 By Trust
Common Stock 11.4K $40.2K $3.54 Feb 13, 2024 Direct
Stock Option (right to buy) 0 Feb 13, 2024 Direct Common Stock

Transactions reported by John W. Smither for Arcutis Biotherapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.